tiprankstipranks
TipRanksTop Financial ExpertsInsidersSorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc. Insider Profile

11 Followers
Sorrento Therapeutics, Inc., Ten Percent Owner at Scilex Holding Company, holds 5.05M shares in Celularity (Ticker: CELU), holds 1.92M shares in Scilex Holding Company (Ticker: SCLX).
tipranks
Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.
Scilex Holding Company (SCLX)
Ten Percent Owner

Not Ranked
Sorrento Therapeutics, Inc. has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$4M
72.70%
27.30%
A breakdown of Sorrento Therapeutics, Inc.'s holdings

Insider Roles

Scilex Holding Company
(SCLX)
Ten Percent Owner
Celularity
(CELU)
Ten Percent Owner
Roles that Sorrento Therapeutics, Inc. holds in companies

Most Profitable Insider Trade

Currently, no data available
The most profitable trade made by Sorrento Therapeutics, Inc.

Sorrento Therapeutics, Inc.'s Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Scilex Holding Company
Sep 25, 2023
Ten Percent Owner
Uninformative Sell
$2.84M
Celularity
Oct 05, 2023
Ten Percent Owner
Uninformative Sell
$1.07M
List of latest transactions for each holding click on a transaction to see Sorrento Therapeutics, Inc.'s performance on stock

Sorrento Therapeutics, Inc. insider profile FAQ

What is the percentage of profitable transactions made by Sorrento Therapeutics, Inc.?
The percentage of profitable transactions made by Sorrento Therapeutics, Inc. is ―.
    What is the average return per transaction made by Sorrento Therapeutics, Inc.?
    The average return per transaction made by Sorrento Therapeutics, Inc. is ―.
      What stocks does Sorrento Therapeutics, Inc. hold?
      Sorrento Therapeutics, Inc. holds: SCLX, CELU stocks.
        What was Sorrento Therapeutics, Inc.’s latest transaction?
        Sorrento Therapeutics, Inc. latest transaction was an Uninformative Sell of ―.
          What was Sorrento Therapeutics, Inc.'s most profitable transaction?
          Sorrento Therapeutics, Inc.’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
            What is Sorrento Therapeutics, Inc.'s role in Scilex Holding Company?
            Sorrento Therapeutics, Inc.'s role in Scilex Holding Company is Ten Percent Owner.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.